Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.3% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
36
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
0.9% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
21
users have liked this narrative
12
users have commented on this narrative
26
users have followed this narrative
14 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
7
users have commented on this narrative
25
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
43.2% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
ANI Pharmaceuticals
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Emerging Markets And Aging Populations Will Expand Patient Access
Key Takeaways Strong momentum in rare disease and retina drug franchises, plus manufacturing efficiency, is fueling outsized revenue growth and expanding margins via product and market diversification. Domestic manufacturing focus and strategic acquisitions enhance supply chain resiliency and position ANI to capitalize on industry patent cliffs and emerging healthcare trends.
View narrative
US$118.67
FV
23.9% undervalued
intrinsic discount
16.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Angi
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Digital Adoption And Demographic Shifts Will Power Platform Evolution
Key Takeaways Technology investments in AI and platform unification, along with a strategic shift toward higher-value revenue, are expected to accelerate margins, retention, and long-term earnings growth. Increasing home services digitization and an expanded market focus position Angi for ongoing demand growth, deeper market penetration, and a stronger competitive moat.
View narrative
US$32.00
FV
44.3% undervalued
intrinsic discount
2.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Centene
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
Rising Regulatory Pressure And Contracting Medicaid Will Squeeze Margins
Key Takeaways Intensifying regulatory scrutiny, demographic headwinds, and operational inefficiencies threaten Centene's profitability and margin stability in both Medicaid and Marketplace segments. Competitive pressures from technological disruption and dependence on government contracts raise risks of revenue attrition and long-term earnings volatility.
View narrative
US$24.00
FV
21.2% overvalued
intrinsic discount
4.29%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Sally Beauty Holdings
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Inclusive And At-Home Beauty Trends Will Drive Market Renewal
Key Takeaways Accelerated operational efficiency and digital innovation initiatives are driving stronger-than-expected operating margin and digital sales growth, positioning Sally Beauty for outsized profitability. Investments in at-home solutions, diverse product expansion, and inventory optimization are fueling top-line momentum, deeper customer loyalty, and enhanced shareholder returns.
View narrative
US$15.00
FV
9.9% undervalued
intrinsic discount
1.99%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
InMode
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Aging And Wellness Trends Will Boost Med Tech Amid Risks
Key Takeaways New wellness platform and likely regulatory clearances could unlock major, underserved medical markets, significantly expanding growth opportunities in devices and recurring revenue streams. Aggressive global expansion and shifting demographics are expected to drive sustained international growth, higher margins, and increasing profitability through premium product adoption and recurring sales.
View narrative
US$21.00
FV
30.6% undervalued
intrinsic discount
5.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
5 days ago
author updated this narrative
Dynavax Technologies
AN
AnalystHighTarget
Consensus Narrative from 4 Analysts
Emerging Vaccine Demand From Aging Populations Will Reshape Markets
Key Takeaways Exceptional growth in vaccine sales, pipeline innovation, and strategic partnerships position Dynavax for significant market disruption and long-term profit upside. Asset-light model and capital discipline enable flexible expansion, further pipeline investment, and accelerating shareholder returns beyond basic operational growth.
View narrative
US$32.00
FV
67.5% undervalued
intrinsic discount
18.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
KLG
WK Kellogg Co
AN
AnalystHighTarget
Consensus Narrative from 8 Analysts
Health Focus And Urban Lifestyles Will Drive Cereal Success
Key Takeaways Emphasis on health-focused product innovation and strong brand marketing is driving premium pricing, market share gains, and supporting sustained revenue and margin growth. Supply chain modernization and cost optimization post-spin-off are set to significantly boost profitability and enhance long-term earnings leverage.
View narrative
US$24.30
FV
5.4% undervalued
intrinsic discount
0.18%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Bloomin' Brands
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Digital Investments And International Expansion Will Unlock New Potential
Key Takeaways Aggressive menu optimization, tech-driven operations, and a cultural leadership shift position the company for sustained margin expansion and consistent long-term earnings growth. Expanded digital channels and evolving premium offerings align with younger diners' preferences, supporting faster, more profitable growth and increased discretionary spending per customer.
View narrative
US$11.05
FV
35.3% undervalued
intrinsic discount
2.11%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Select Water Solutions
AN
AnalystHighTarget
Consensus Narrative from 6 Analysts
Rising Global Water Scarcity And ESG Will Unlock Efficient Recycling
Key Takeaways Select is positioned for substantial recurring revenue and margin expansion due to superior infrastructure growth, unique business models, and operational leverage across geographies. Regulatory pressures, water scarcity, and electrification trends will drive premium pricing, new revenue streams, and strong long-term cash flow opportunities.
View narrative
US$18.00
FV
53.9% undervalued
intrinsic discount
-1.97%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies